What is the latest GLAND stock price?
The latest stored price for GLAND is Rs 3,385.90 as of 2026-11-16.
GLAND PHARMA LIMITED is a mid-cap stock in Healthcare. This Gimli page shows the latest available GLAND price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for GLAND is Rs 3,385.90 as of 2026-11-16.
GLAND is above 50DMA, above 200DMA. The latest 50DMA is 3,017.22 and the latest 200DMA is 2,350.15.
GLAND has PE 45.14, ROE +12.67%, and ROCE +17.50% in Gimli's latest available snapshot.
GLAND has returned +11.25% over 1 month, +14.00% over 3 months, and +85.02% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 1,833.59 cr | 553.09 cr | 290.76 cr | 17.62 |
| 2026-06-30 | 1,345.46 cr | 532.33 cr | 317.00 cr | 19.23 |
| 2026-03-31 | 1,742.79 cr | 624.49 cr | 366.68 cr | 22.26 |
| 2025-12-31 | 1,695.36 cr | 473.70 cr | 261.48 cr | 15.87 |
| 2025-09-30 | 1,571.00 cr | 398.05 cr | 183.68 cr | nan |
| 2025-06-30 | 1,505.62 cr | 425.29 cr | 215.48 cr | 13.08 |
| 2025-03-31 | 1,424.91 cr | 391.54 cr | 186.54 cr | 11.32 |
| 2024-12-31 | 1,384.05 cr | 418.45 cr | 204.69 cr | 12.42 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 6,430.65 cr | 1,921.53 cr | 1,027.32 cr | 62.35 |
| 2025-03-31 | 5,616.50 cr | 1,482.53 cr | 698.53 cr | 42.40 |
| 2024-03-31 | 5,641.73 cr | 1,498.90 cr | 772.46 cr | 46.90 |
| 2023-03-31 | 3,591.86 cr | 1,207.61 cr | 781.04 cr | 47.44 |
| 2022-03-31 | 4,624.65 cr | 1,732.25 cr | 1,212.16 cr | 73.67 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 12,510.85 cr | 3,359.11 cr | 283.59 cr | 10,357.95 cr |
| 2025-03-31 | 11,224.92 cr | 2,556.19 cr | 313.73 cr | 9,150.74 cr |
| 2024-03-31 | 10,661.25 cr | 357.09 cr | 372.17 cr | 8,723.84 cr |
| 2023-03-31 | 8,777.53 cr | 1,908.89 cr | 4.45 cr | 7,958.72 cr |
| 2022-03-31 | 7,833.62 cr | 294.82 cr | 4.74 cr | 7,157.62 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 1,031.39 cr | 536.96 cr | n/a |
| 2025-03-31 | 914.73 cr | 520.56 cr | n/a |
| 2024-03-31 | 996.80 cr | 598.54 cr | n/a |
| 2023-03-31 | 363.97 cr | 140.85 cr | n/a |
| 2022-03-31 | 790.77 cr | 268.65 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +45.75% | +10.36% | +33.21% | +29.52% | +10.66% | +0.00% |
| 2026-06-30 | +51.77% | +8.74% | +30.44% | +28.23% | +9.05% | +0.00% |
| 2026-03-31 | +51.83% | +7.30% | +33.35% | +31.78% | +7.52% | +0.00% |
| 2025-12-31 | +51.83% | +7.58% | +32.98% | +31.42% | +7.61% | +0.00% |
| 2025-09-30 | +51.83% | +7.91% | +32.64% | +30.19% | +7.63% | +0.00% |
| 2025-06-30 | +51.83% | +7.39% | +32.85% | +30.67% | +7.93% | +0.00% |
| 2025-03-31 | +51.83% | +6.90% | +33.27% | +31.16% | +7.99% | +0.00% |
| 2024-12-31 | +51.83% | +5.04% | +34.80% | +32.37% | +8.33% | +0.00% |
| 2024-09-30 | +51.83% | +4.47% | +35.37% | +32.83% | +8.32% | +0.00% |
| 2024-06-30 | +51.83% | +6.88% | +32.83% | +30.53% | +8.45% | +0.00% |
| 2024-03-31 | +57.86% | +3.59% | +25.23% | +23.01% | +13.32% | +0.00% |
| 2023-12-31 | +57.86% | +4.04% | +24.17% | +21.34% | +13.93% | +0.00% |
| 2023-09-30 | +57.86% | +4.91% | +22.45% | +19.79% | +14.78% | +0.00% |
| 2023-06-30 | +57.86% | +2.80% | +23.38% | +20.48% | +15.96% | +0.00% |
| 2023-03-31 | +57.86% | +4.33% | +23.23% | +20.25% | +14.58% | +0.00% |
| 2022-12-31 | +57.86% | +4.67% | +23.13% | +19.49% | +14.33% | +0.00% |
| 2022-09-30 | +57.86% | +6.10% | +21.93% | +18.48% | +14.11% | +0.00% |
| 2022-06-30 | +57.87% | +0.00% | +26.77% | n/a | n/a | +0.00% |
| 2022-03-31 | +58.00% | +0.00% | +23.18% | n/a | n/a | +0.00% |
| 2021-12-31 | +58.00% | +0.00% | +22.96% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.